Change Lives, Participate in a Clinical Trial, And Get Paid

It’s your involvement that helps improve treatments and access to innovative care for all patients. Find paid clinical trials in Louisville KY at Butchertown Clinical Trials.

Partners / Sponsors – Learn More Patients – View Open Trials

Located Near Downtown Louisville, KY, in Butchertown

1536 Story Ave
Louisville, KY 40206
Call (502) 219-7700

Office hours:
Mon – Fri: 8 AM – 5 PM EST
Sat – Sun: Closed

FDA Approvals
Clinical Trials
Years of Principal Investigator Experience
Trialed Medical Conditions
bct building

About Butchertown Clinical Trials

Butchertown Clinical Trials is a clinical trials research site in Louisville, KY, specializing in ophthalmic, vaccine, adult medicine, and metabolic disease clinical trials. Our mission is to help improve treatments and access to innovative care for all patients by involving them in clinical trials. We regularly recruit study subjects for paid clinical trials sponsored by pharmaceutical companies and medical equipment firms to prove the usefulness of new treatments, surgical implants, or diagnostic medical devices.

Learn More

How We Do Dry Eye Research and Paid Clinical Trials in Louisville, KY

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

How Does It Work?
dry eye research

We are always enrolling for our clinical research trials and studies for:

  • Dry Eye Disease
  • Cataract
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Corneal Dystrophy
  • Geographic Atrophy
  • LASIK and post-operative conditions
  • Conjunctivitis
  • Conditions of the Eye and Ocular Adnexa
  • Environmental Allergies
  • Seasonal Allergies
  • Presbyopia
  • Hypertension
  • Hypothyroid
  • High Cholesterol
  • Nutrition and Weight Loss
  • Type I and Type II Diabetes

New Posts From the Blog

Olivia Kaiser Promoted to Clinical Trials Site Manager

Olivia Kaiser, who began her career in clinical trials as a subject recruiter and was promoted to Clinical Trials Team Lead, has been promoted to Site Manager at Butchertown Clinical Trials. In Olivia’s new role, she will have expanded planning and trial coordination duties as the site is poised for additional growth and is currently undergoing an expansion allowing it…

You May Benefit By Participating in a Clinical Trial

Our Butchertown Clinical Trials division works with our doctors and patients to test new treatments, or variations of existing treatments, to determine if they are more effective, or safer than existing treatments, and therefore worthy of FDA approval. Under the direction of The Doctors of The Eye Care Institute, our clinical-trials-only staff of almost a dozen science-oriented individuals works to…

Taking A Weight Loss Drug and Worried About Vision Loss?

A recent study* was published showing an increase in eye disease, for those taking Semaglutide, GLP-1 Antagonist, for weight loss. Two of these three medications, Ozempic and Rybelsus, are FDA-approved for treating Type II Diabetes. These are often used “off-label” for weight loss. Wegovy is FDA-approved for those 12 and over to treat obesity. The increase in the incidence of…

Butchertown Clinical Trials and The Eye Care Institute Announce 21st FDA Approval

LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for the treatment of ocular inflammation and pain following ocular surgery. Dr. Brennan P. Greene, MD. continued “Although much work remains to eradicate post-operative pain and inflammation, this…

Butchertown Clinical Trials and The Eye Care Institute Announce Our 20th FDA Approval Qlosi™, an Eyedrop for the Treatment of Presbyopia

Orasis Pharmaceuticals Announces FDA Approval of QLOSI™ (pilocarpine hydrochloride ophthalmic solution) 0.4% for the Treatment of Presbyopia Ponte Vedra, FL, October 18, 2023 QLOSI (pronounced CLOH-see) is a prescription eye drop that can be used daily or as needed, up to twice per day. QLOSI demonstrated efficacy 20 minutes after administration and can last up to 8 hours. John C….

Receive Announcements on Upcoming Research Trials

We regularly recruit patients (study subjects) to enroll in dry eye research trials and paid clinical trials that are sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices.

Get Started Today

We regularly recruit patients (study subjects) to enroll in clinical trials sponsored by pharmaceutical companies, surgical and medical equipment firms, and others attempting to prove the usefulness of a new pharmaceutical agent, treatments, surgical implants, or diagnostic medical devices. View open trials today.

Contact Us